Synthesis and antitumor evaluation of nitrovinyl biphenyls: Anticancer agents based on allocolchicines

ChemMedChem

Volumn 6, Issue 5, 2011, Pages 859-868

  Jain, Nishant ^a   Yada, Divya ^a   Shaik, Thokhir B ^a   Vasantha, Galanki ^a   Reddy, P Surendra ^a   Kalivendi, Shasi V ^a   Sreedhar, B ^a  

^a INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

Author keywords

Antitumor agents; Colchicines; Cytotoxicity; Nitrovinyl biphenyls; Tubulin polymerization

Indexed keywords

(E) 1 (2',3',4' TRIMETHOXY 6' (2 NITROVINYL)BIPHENYL 4 YL)ETHANONE; (E) METHYL 2',3',4' TRIMETHOXY 6'(2 NITROVINYL)BIPHENYL 4 CARBOXYLATE; ALLOCOLCHICINE; ANTINEOPLASTIC AGENT; AURORA B KINASE; BIPHENYL DERIVATIVE; COLCHICINE; CYCLIN B1; MESSENGER RNA; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG SCREENING; DRUG SYNTHESIS; FLOW CYTOMETRY; HELA CELL; HUMAN; HUMAN CELL; IC 50; MICROTUBULE ASSEMBLY; MITOSIS INHIBITION; PRIORITY JOURNAL; UPREGULATION;

ANTINEOPLASTIC AGENTS; BIPHENYL COMPOUNDS; CELL DIVISION; CELL LINE, TUMOR; COLCHICINE; CYCLIN B1; DRUG SCREENING ASSAYS, ANTITUMOR; G2 PHASE; HUMANS; NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; TUBULIN; TUBULIN MODULATORS;

EID: 79955020387     PISSN: 18607179     EISSN: 18607187     Source Type: Journal    
DOI: 10.1002/cmdc.201100019     Document Type: Article

References (47)

1. A. P. Dustin, Microtubules, Springer, Heidelberg, 1984.
2. M. A. Jordan, L. Wilson, Nat. Rev. Cancer 2004, 4, 253-265.
3. M. N. Islam, M. N. Iskander, Mini Rev. Med. Chem. 2004, 4, 1077-1104;
4. J. A. Hadfield, S. Ducki, N. Hirst, A. T. McGown, Prog. Cell Cycle Res. 2003, 5, 309-325;
5. E. Hamel, Med. Res. Rev. 1996, 16, 207-231.
6. D. Hanahan, R. A. Weinberg, Cell 2000, 100, 57-70.
7. I. E. L. M. Kuppens, Curr. Clin. Pharmacol. 2006, 1, 57-70.
8. A. Jordan, J. A. Hadfield, N. J. Lawrence, A. T. McGown, Med. Res. Rev. 1998, 18, 259-296;
9. A. Kiselyov, K. V. Balakin, S. E. Tkachenko, N. Savchuk, A. V. Ivachtchenko, Anti-Cancer Agents Med. Chem. 2007, 7, 189-208.
10. B. Bhattacharyya, D. Panda, S. Gupta, M. Banerjee, Med. Res. Rev. 2008, 28, 155-183.
11. O. Boye, A. Brossi, The Alkaloids, Vol.41 (Eds.: A. Brossi, G.A. Cordell), Academic Press, New York, 1992, p.125.
12. G.-J. Kang, Z. Getahun, A. Muzaffar, A. Brossi, E. Hamel, J. Biol. Chem. 1990, 265, 10255-10259.
13. U. Berg, H. Bladh, Acta Chem. Scand. 1998, 52, 1380-1385.
14. R. Brecht, G. Seitz, D. Guenard, S. Thoret, Bioorg. Med. Chem. 2000, 8, 557-562;
15. S. Bergemann, R. Brecht, F. Buttner, D. Guenard, R. Gust, G. Seitz, M. T. Stubbs, S. Thoret, Bioorg. Med. Chem. 2003, 11, 1269-1281.
16. O. Boyé, A. Brossi, H. J. C. Yeh, E. Hamel, B. Wegrzynski, V. Toome, Can. J. Chem. 1992, 70, 1237-1249.
17. J. M. Andreu, B. Perez-Ramirez, M. J. Gorbunoff, D. Ayala, S. N. Timasheff, Biochemistry 1998, 37, 8356-8368.
18. M. G. Banwell, J. M. Cameron, M. P. Collins, G. T. Crisp, R. W. Gable, E. Hamel, Aust. J. Chem. 1991, 44, 705-728.
19. M. G. Banwell, J. Cameron, M. Corbett, J. R. Dupuche, E. Hamel, J. N. Lambert, C. M. Lin, M. F. Mackay, Aust. J. Chem. 1992, 45, 1967;
20. M. G. Banwell, M.-A. Fam, R. W. Gable, E. Hamel, J. Chem. Soc. Chem. Commun. 1994, 2647-2648.
21. Q. Shi, K. Chen, A. Brossi, P. Verdier-Pinard, E. Hamel, A. T. McPhail, K.-H. Lee, Helv. Chim. Acta 1998, 81, 1023-1037.
22. H. G. T. Graening, Angew. Chem. 2004, 116, 3292-3318; Angew. Chem. Int. Ed. 2004, 43, 3230-3256;
23. S. Djurdjevic, J. R. Green, Org. Lett. 2007, 9, 5505-5508;
24. M. Leblanc, K. Fagnou, Org. Lett. 2005, 7, 2849-2852.
25. P. Appukkuttan, E. V. Eycken, Eur. J. Org. Chem. 2008, 5867-5886;
26. R. W. Wang, L. I. Rebhun, S. M. Kupchan, Cancer Res. 1977, 37, 3071-3079;
27. A. Joncour, A. Decor, J. M. Liu, M. E. TranHuuDau, O. Baudoin, Chem. Eur. J. 2007, 13, 5450-5465.
28. S. Kaap, I. Quentin, D. Tamiru, M. Shaheen, K. Eger, H. Steinfelder, Biochem. Pharmacol. 2003, 65, 603-610.
29. J. H. Kim, J. H. Kim, J. E. Lee, J. E. Lee, I. K. Chung, Mol. Pharmacol. 2003, 63, 1117-1124.
30. C. Sawyers, Nature 2004, 432, 294-297;
31. A. Petrelli, S. Giordano, Curr. Med. Chem. 2008, 15, 422-432;
32. Z. Fu, L. Malureanu, J. Huang, W. Wang, H. Li, J. M. VanDeursen, D. J. Tindall, J. Chen, Nat. Cell Biol. 2008, 10, 1076-1082.
33. A. M. Bode, Z. G. Dong, Nat. Rev. Cancer 2009, 9, 508-516;
34. P. Zhan, X. Y. Liu, Curr. Pharm. Des. 2009, 15, 1893-1917;
35. C. J. Van der Schyf, W. J. Geldenhuys, Neurotherapeutics 2009, 6, 175-186;
36. A. H. Futerman, J. L. Sussman, M. Horowitz, I. Silman, A. Zimran, Trends Pharmacol. Sci. 2004, 25, 147-151;
37. A. Schrattenholz, V. Soskic, Curr. Med. Chem. 2008, 15, 1520-1528.
38. G. Bacher, T. Beckers, P. Emig, T. Klenner, B. Kutscher, B. Nickel, Pure Appl. Chem. 2001, 73, 1459-1464.
39. Y. H. Ling, C. Tornos, R. Perez-Soler, Int. J. Cancer 2001, 91, 393-401;
40. S. C. Shen, T. S. Huang, S. H. Jee, M. L. Kuo, Cell Growth Differ. 1998, 9, 23-29;
41. R. S. DiPaola, Clin. Cancer Res. 2002, 8, 3311-3314.
42. R. J. Vasquez, B. Howell, A. M. Yvon, P. Wadsworth, L. Cassimeris, Mol. Biol. Cel. 1997, 8, 973-985.
43. A. Krämer, J. Lukas, J. Bartek, Cell Cycle 2004, 11, 1390-1393.
44. J. Zhou, K. Gupta, S. Aggarwal, R. Aneja, R. Chandra, D. Panda, H. C. Joshi, Mol. Pharmacol. 2003, 63, 799-807.
45. W. P. Hu, H. S. Yu, P. J. Sung, F. Y. Tsai, Y. K. Shen, L. S. Chang, J. J. Wang, Chem. Res. Toxicol. 2007, 20, 905-912.
46. K. Huber, P. Patel, L. Zhang, H. Evans, A. D. Westwell, P. M. Fischer, S. Chan, S. Martin, Mol. Cancer Ther. 2008, 7, 143-151.
47. A. Kamal, G. Balakishan, G. Ramakrishna, T. B. Shaik, K. Sreekanth, M. Balakrishna, Rajender, D. Dastagiri, S. V. Kalivendi, Eur. J. Med. Chem. 2010, 45, 3870-3884.